Results 71 to 80 of about 6,433 (183)
Omeprazole: Inhibiting the Final Common Pathway to Acid Secretion - The Acid Pump
Canadian Journal of Gastroenterology, 1989 Omeprazole is the first agent in a new therapeutic advance class the proton or acid pump inhibitors which represents a significant therapeutic advance in the treatment of acid related diseases.
A.B.R. Thomson
doaj +1 more source
Getting your report seen in and beyond ABE&M [PDF]
, 2008 Universidade Federal de São Paulo (UNIFESP), Escola Paulista de Medicina (EPM) Department of BiochemistryUNIFESP, EPM, Department of ...
Dias-da-Silva, Magnus Régios
core +2 more sources
Journal of Neuroendocrinology, Volume 37, Issue 8, August 2025.Abstract Pancreatic neuroendocrine tumors (panNETs) are rare pediatric malignancies with age‐specific clinical and biological features. Data on their presentation, management, and outcomes remain limited. This retrospective study analyzed 28 pediatric panNET cases from the German Malignant Endocrine Tumor (MET) Registry enrolled between 1997 and 2024 ...
Katharina Karges +12 more
wiley +1 more source
Evolution of clinical ideas about Zollinger-Ellison syndrome
Терапевтический архив, 2014 The paper gives the current views of the diagnosis and treatment of Zollinger-Ellison syndrome (ZES). It underlines the importance of including ZES in differential diagnosis in patient with frequently recurrent and standard-dose proton pump inhibitor ...
I V Maev +3 more
doaj
Gastritisek es gastropathiak. [PDF]
, 2014 Alterations of the stomach mucosa in response to different adverse effects result in various morphological and clinical symptoms. Gastric mucosa alterations can be classified on the bases of diverse viewpoints.
Herszényi, László +4 more
core +1 more source
Predictors of Mortality in Patients With Multiple Endocrine Neoplasia Type 1
Clinical Endocrinology, Volume 103, Issue 1, Page 50-56, July 2025.SUMMARY Objective Multiple Endocrine Neoplasia Type 1 (MEN 1) is an autosomal dominant disease predisposing to hyperplasia and neoplasia in diverse endocrine tissues. Patients typically present with endocrine abnormalities before the age of 30 years and have reduced life expectancy.
Jasmine J. Zhu, John R Burgess
wiley +1 more source
Tumor carcinóide de estômago tipo 1
Revista do Colégio Brasileiro de CirurgiõesGastric carcinoid occurs in less than 1% of gastric neoplasias and around 2% of carcinoids tumors. They are classified into three forms: type 1, associated with atrophic gastritis, type 2, associated with multiple endocrine neoplasia 1 and Zollinger ...
Rubens Valarini +2 more
doaj +1 more source
Rapid healing of a patient with dramatic subacute combined degeneration of spinal cord: a case report [PDF]
, 2017 Background: Prevalence of cobalamin deficiency is high especially in older patients and an immediate therapy start is necessary to prevent irreversible neurological damages. Unfortunately, the diagnosis of cobalamin deficiency is difficult and at present,
Roessler, Florian C., Wolff, Stephanie
core +1 more source
United European Gastroenterology Journal, Volume 13, Issue 5, Page 773-797, June 2025.ABSTRACT Malabsorption is a complex and multifaceted condition characterised by the defective passage of nutrients into the blood and lymphatic streams. Several congenital or acquired disorders may cause either selective or global malabsorption in both children and adults, such as cystic fibrosis, exocrine pancreatic insufficiency (EPI), coeliac ...
Marco Vincenzo Lenti +29 more
wiley +1 more source
Zollinger–Ellison syndrome: modern aspects of diagnostics and treatment
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2014 The aim of review. To reflect modern concepts on clinic, diagnostics and treatment of Zollinger–Ellison syndrome (ZES).Key points. ZES is rare disease related to intragastric hyperacidity.
I. V. Mayev +3 more
doaj